albendazole has been researched along with atovaquone in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Brun, R; Dong, Y; Hemphill, A; Kaiser, M; Matile, H; Nehrbass-Stuedli, A; Vennerstrom, JL; Wang, X; Wittlin, S | 1 |
Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ahn, KJ; Anderson, MO; Baum, J; Belanger, B; Chaplan, CA; Cheung, A; Churchyard, A; Crespo, B; DiBernardo, C; Eagon, S; Eribez, K; Falade, MO; Gamo, FJ; García-Barbazán, I; Guy, RK; Hammill, JT; Kashtanova, AS; Kim, K; Kimball, JJ; Koch, G; Laleu, B; Lazaro, H; Loop, L; Mittal, N; Rice, AL; Sigal, M; Takahashi, R; Tryhorn, JE; Wilkinson, SP; Winzeler, EA; Yniguez, K | 1 |
Asakawa, AH; Brockmeyer, F; Casandra, D; Huang, L; Kyle, DE; LaCrue, AN; Maher, SP; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Padin-Irizarry, V; Parvatkar, PT; Sakhno, YI; Zhao, Y | 1 |
Angelici, E; Canipari, R; Colombo, D; Contini, C; Cultrera, R; Prini, E; Sechi, T | 1 |
Dressman, JB; Reppas, C | 1 |
Enkai, S; Inaoka, DK; Irie, T; Kita, K; Kouguchi, H; Yagi, K | 1 |
2 review(s) available for albendazole and atovaquone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.
Topics: Administration, Oral; Albendazole; Animals; Antiprotozoal Agents; Atovaquone; Biopharmaceutics; Buffers; Chemistry, Pharmaceutical; Gastric Emptying; Gastric Mucosa; Humans; Intestine, Small; Models, Biological; Naphthoquinones; Particle Size; Solubility | 2000 |
6 other study(ies) available for albendazole and atovaquone
Article | Year |
---|---|
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
Topics: Animals; Antimalarials; Artemisinins; Eukaryota; Heterocyclic Compounds, 1-Ring; Iron; Parasitic Sensitivity Tests; Peroxides; Plasmodium falciparum; Sesquiterpenes; Spiro Compounds | 2007 |
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship | 2014 |
Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-
Topics: Antimalarials; Cell Line; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Pyridines; Structure-Activity Relationship | 2020 |
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Topics: Administration, Oral; Animals; Antimalarials; Cyclization; Disease Models, Animal; Ethers; Female; Half-Life; Hydrogen-Ion Concentration; Malaria; Mice; Mice, Inbred BALB C; Plasmodium falciparum; Prodrugs; Quinolones; Solubility; Structure-Activity Relationship | 2021 |
Employment of terbinafine against Pneumocystis carinii infection in rat models.
Topics: Administration, Oral; Albendazole; Animals; Antifungal Agents; Atovaquone; Drug Administration Schedule; Immunosuppression Therapy; Lung; Naphthalenes; Naphthoquinones; Pneumonia, Pneumocystis; Rats; Rats, Sprague-Dawley; Terbinafine; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
Topics: Albendazole; Animals; Antiparasitic Agents; Atovaquone; Drug Therapy, Combination; Echinococcosis; Echinococcus multilocularis; Female; Mice; Mice, Inbred BALB C | 2021 |